Impact of NAFLD and Fibrosis on Adverse Cardiovascular Events in Patients With Hypertension
NAFLD and related liver fibrosis are associated with a higher risk of incident CVD and mortality in hypertensives. NAFLD and related liver fibrosis seem to partially mediate hypertension-induced CVD and mortality.
Authors
- Xiaoyu Wang (ORCID: https://orcid.org/0009-0008-5362-3195)
- Tingya Wan
- Liao Wang (ORCID: https://orcid.org/0000-0002-4198-9084)
- Xu Jiang (ORCID: https://orcid.org/0000-0002-6933-5453)
- Yanqiu Huang (ORCID: https://orcid.org/0009-0006-9317-2283)
- Xiaoguang Li (ORCID: https://orcid.org/0000-0002-2362-9130)
- Yang Yang (ORCID: https://orcid.org/0000-0001-8714-9729)
- Juan Ji (ORCID: https://orcid.org/0000-0003-4045-5205)
- Hong Gao
- Hui Wang (ORCID: https://orcid.org/0000-0003-4463-8121)
- Yang Yang
- Yuemei Hong
Institutions
- Johns Hopkins University (US)
- Shanghai Jiao Tong University (CN)
- Renji Hospital (CN)
- Shanghai Ninth People's Hospital (CN)
- Community Health Center (US)
- Shanghai Institute of Hematology (CN)
Publication Details
- Journal
- Hypertension
- Published
- 2025-04-23
- DOI
- https://doi.org/10.1161/hypertensionaha.124.24252
- Citations
- 14
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 18.96